Metagenomi Therapeutics Inc.
Organization details
- Legal name
- Metagenomi Therapeutics Inc.
- Former names
- Metagenomi, Inc. Metagenomi Technologies, LLC
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters city
- Emeryville
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MGX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001785279
- EIN
- 81-3909017
Board of directors
-
Brian C. Thomas · Director · Chief Executive OfficerSince 2024
-
Eric Bjerkholt · DirectorSince 2025
-
Jian Irish · Director · See RemarksSince 2024
-
Juergen Eckhardt · DirectorSince 2024
-
Laurence Reid · DirectorSince 2025
-
Sebastian Bernales · DirectorSince 2024
-
Willard H. Dere · DirectorSince 2024
Chief executives
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 0
-25% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Director election results
Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
83.6%
-
94.5%
Board connections
2 of this board's directors also sit on 5 other boards. 5 are in the same sector.
-
BioMarin Pharmaceutical Inc. Same sectorvia Willard H. Dere
-
CalciMedica Inc. Same sectorvia Eric Bjerkholt
-
Cerus Corporation Same sectorvia Eric Bjerkholt
-
Seres Therapeutics Inc. Same sectorvia Willard H. Dere
-
Surrozen Inc. Same sectorvia Eric Bjerkholt
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $23,401
- 2 purchases by 1 insider
- Sold, last 12 months
- $33,076
- 13 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 9, 2026 | Laurence Reid Director | Open-market purchase | +19,883 | $1.17 | $23,263 |
| Sep 9, 2026 | Laurence Reid Director | Open-market purchase | +117 | $1.18 | $138 |
| Sep 8, 2026 | Jian Irish Director, Officer (See Remarks) | Open-market sale | −2,140 | $1.16 | $2,482 |
| Sep 8, 2026 | Wapnick Pamela Officer (Chief Financial Officer) | Open-market sale | −1,911 | $1.16 | $2,217 |
| Sep 8, 2026 | Wein Matthew Officer (See Remarks) | Open-market sale | −358 | $1.16 | $415 |
| Jun 5, 2026 | Wapnick Pamela Officer (Chief Financial Officer) | Open-market sale | −2,884 | $1.30 | $3,749 |
| Jun 5, 2026 | Jian Irish Director, Officer (See Remarks) | Open-market sale | −3,737 | $1.30 | $4,858 |
| Jun 5, 2026 | Wein Matthew Officer (See Remarks) | Open-market sale | −558 | $1.30 | $725 |
| Apr 1, 2026 | Jian Irish Director, Officer (See Remarks) | Grant or award | +46,000 | — | — |
| Apr 1, 2026 | Wein Matthew Officer (See Remarks) | Grant or award | +11,000 | — | — |
| Apr 1, 2026 | Wapnick Pamela Officer (Chief Financial Officer) | Grant or award | +24,000 | — | — |
| Mar 5, 2026 | Wapnick Pamela Officer (Chief Financial Officer) | Open-market sale | −1,581 | $1.60 | $2,530 |
| Mar 5, 2026 | Wein Matthew Officer (See Remarks) | Open-market sale | −482 | $1.60 | $771 |
| Mar 5, 2026 | Jian Irish Director, Officer (Chief Executive Officer) | Open-market sale | −1,607 | $1.60 | $2,571 |
| Dec 5, 2025 | Brian C. Thomas Director | Open-market sale | −3,830 | $1.77 | $6,779 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Metagenomi Therapeutics Inc.
Who is the CEO of Metagenomi Therapeutics Inc.?
Brian C. Thomas has been Metagenomi Therapeutics Inc.'s Chief Executive Officer since February 2024.
How many directors are on Metagenomi Therapeutics Inc.'s board?
Metagenomi Therapeutics Inc.'s board has 7 directors: Brian C. Thomas, Eric Bjerkholt, Jian Irish, Juergen Eckhardt, Laurence Reid, Sebastian Bernales and Willard H. Dere.
Are Metagenomi Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Metagenomi Therapeutics Inc. insiders bought $23,401 of shares in 2 purchases and sold $33,076 of shares in 13 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="metagenomi-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.